Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
CLPT Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
12.40%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
-24.80%
CLPT Stock Analysis
CLPT
PE Ratio:
CLPT
PEG Ratio:
Not Available
CLPT
Forward EPS Growth (12 month):
0.00%
CLPT
PS Ratio:
9.8
CLPT
PSG Ratio:
0.5
CLPT
Forward Revenue Growth (12 month):
20.50%
CLPT Articles
No data was found